1 period filed. Holdings below describe the selected month only.
NPORT-P · filed 2026-05-27
5 classes of this one portfolio · 0 exchange-listed
| Class ID | Symbol | Status | Security in the master | Type |
|---|---|---|---|---|
| C000002313 | PACAX | NOT_LISTED | not exchange-listed | — |
| C000002314 | PACBX | NOT_LISTED | not exchange-listed | — |
| C000002315 | PACCX | NOT_LISTED | not exchange-listed | — |
| C000002317 | PACRX | NOT_LISTED | not exchange-listed | — |
| C000002318 | PACYX | NOT_LISTED | not exchange-listed | — |
as filed
N-PORT Item C.4.a
N-PORT Item C.4.b
2,287 positions in this filing
| Issuer↕ | In master | CUSIP / ISIN | Asset | Balance↕ | Value↕ | Weight▼ | Country |
|---|---|---|---|---|---|---|---|
| Northrop Grumman Corp. | NOC | 666807102 US6668071029 | EC CORP | 2,037 NS | $1.39M | 0.172% |
| US |
| Hoya Corp. | — | — JP3837800006 | EC CORP | 7,900 NS | $1.37M JPY | 0.169% | JP |
| American Tower Corp. | AMT | 03027X100 US03027X1000 | EC CORP | 7,927 NS | $1.37M | 0.169% | US |
| Valero Energy Corp. | VLO | 91913Y100 US91913Y1001 | EC CORP | 5,529 NS | $1.37M | 0.169% | US |
| Simon Property Group, Inc. | SPG | 828806109 US8288061091 | EC CORP | 7,158 NS | $1.34M | 0.165% | US |
| Thermo Fisher Scientific, Inc. | TMO | 883556102 US8835561023 | EC CORP | 2,686 NS | $1.32M | 0.163% | US |
| PulteGroup, Inc. | PHM | 745867101 US7458671010 | EC CORP | 11,218 NS | $1.32M | 0.163% | US |
| Corteva, Inc. | CTVA | 22052L104 US22052L1044 | EC CORP | 15,326 NS | $1.28M | 0.158% | US |
| ABB Ltd. | — | — CH0012221716 | EC CORP | 15,735 NS | $1.28M CHF | 0.158% | CH |
| Sanofi SA | — | — FR0000120578 | EC CORP | 13,218 NS | $1.28M EUR | 0.158% | FR |
| Banco Santander SA | — | 05971KAL3 US05971KAL35 | DBT CORP | 1,400,000 PA | $1.26M | 0.155% | ES |
| PNC Financial Services Group, Inc. (The) | PNC | 693475105 US6934751057 | EC CORP | 6,021 NS | $1.25M | 0.155% | US |
| FNMA FNMA, 30 Year | — | 31418CBF0 US31418CBF05 | ABS-MBS USGSE | 1,375,823.36 PA | $1.24M | 0.153% | US |
| Incyte Corp. | INCY | 45337C102 US45337C1027 | EC CORP | 13,054 NS | $1.23M | 0.152% | US |
| CME Group, Inc. | CME | 12572Q105 US12572Q1058 | EC CORP | 4,141 NS | $1.22M | 0.151% | US |
| GNMA GNMA II, Single-family, 30 Year | — | 21H052645 US21H0526457 | ABS-MBS USGA | 1,200,000 PA | $1.21M | 0.149% | US |
| Allstate Corp. (The) | ALL | 020002101 US0200021014 | EC CORP | 5,776 NS | $1.20M | 0.148% | US |
| Airbus SE | — | — NL0000235190 | EC CORP | 6,295 NS | $1.19M EUR | 0.147% | NL |
| Autodesk, Inc. | ADSK | 052769106 US0527691069 | EC CORP | 4,911 NS | $1.18M | 0.145% | US |
| Trane Technologies plc | TT | — IE00BK9ZQ967 | EC CORP | 2,783 NS | $1.16M | 0.143% | IE |
| Cadence Design Systems, Inc. | CDNS | 127387108 US1273871087 | EC CORP | 4,173 NS | $1.16M | 0.143% | US |
| Boston Scientific Corp. | BSX | 101137107 US1011371077 | EC CORP | 18,448 NS | $1.16M | 0.143% | US |
| Advanced Micro Devices, Inc. | AMD | 007903107 US0079031078 | EC CORP | 5,642 NS | $1.15M | 0.142% | US |
| HSBC Holdings plc | — | — GB0005405286 | EC CORP | 69,626 NS | $1.14M GBP | 0.141% | GB |
| ConocoPhillips | COP | 20825C104 US20825C1045 | EC CORP | 8,644 NS | $1.14M | 0.141% | US |
| Bristol-Myers Squibb Co. | BMY | 110122108 US1101221083 | EC CORP | 18,778 NS | $1.14M | 0.141% | US |
| Glencore plc | — | — JE00B4T3BW64 | EC CORP | 148,584 NS | $1.13M GBP | 0.139% | JE |
| Southwest Airlines Co. | LUV | 844741108 US8447411088 | EC CORP | 29,883 NS | $1.12M | 0.139% | US |
| FHLMC FHLMC, Series 5466, Class FG | — | 3137HFPC3 US3137HFPC37 | ABS-MBS USGSE | 1,097,923.96 PA | $1.10M | 0.136% | US |
| AstraZeneca plc | AZN | — GB0009895292 | EC CORP | 5,614 NS | $1.10M GBP | 0.136% | GB |
| AstraZeneca plc | AZN | — GB0009895292 | EC CORP | 5,538 NS | $1.09M | 0.135% | GB |
| JPMorgan Chase & Co. | JPM | 46625H100 US46625H1005 | EC CORP | 3,672 NS | $1.08M | 0.133% | US |
| Mitsubishi UFJ Financial Group, Inc. | — | — JP3902900004 | EC CORP | 63,700 NS | $1.08M JPY | 0.133% | JP |
| PepsiCo, Inc. | PEP | 713448108 US7134481081 | EC CORP | 6,917 NS | $1.07M | 0.133% | US |
| VCAT LLC VCAT LLC, Series 2026-NPL2, Class A1 | — | 921968AA1 US921968AA13 | ABS-MBS CORP | 1,065,866.82 PA | $1.06M | 0.131% | US |
| FNMA FNMA, 30 Year | — | 3140QRSK0 US3140QRSK00 | ABS-MBS USGSE | 1,012,947.24 PA | $1.05M | 0.130% | US |
| Bank of America Corp. | — | 06051GKL2 US06051GKL22 | DBT CORP | 1,133,000 PA | $1.05M | 0.130% | US |
| Monster Beverage Corp. | MNST | 61174X109 US61174X1090 | EC CORP | 14,420 NS | $1.04M | 0.129% | US |
| FNMA FNMA, 30 Year | — | 3140XB3D0 US3140XB3D09 | ABS-MBS USGSE | 1,206,192.96 PA | $1.04M | 0.129% | US |
| Broadcom Corp. / Broadcom Cayman Finance Ltd. | — | 11134LAR0 US11134LAR06 | DBT CORP | 1,053,000 PA | $1.04M | 0.129% | US |
| FNMA FNMA, 30 Year | — | 3140J9SN2 US3140J9SN27 | ABS-MBS USGSE | 1,155,579 PA | $1.04M | 0.128% | US |
| TotalEnergies SE | TTE | — FR0000120271 | EC CORP | 11,107 NS | $1.02M EUR | 0.126% | FR |
| Invitation Homes, Inc. | INVH | 46187W107 US46187W1071 | EC CORP | 40,371 NS | $1.00M | 0.124% | US |
| UnitedHealth Group, Inc. | UNH | 91324P102 US91324P1021 | EC CORP | 3,705 NS | $1.00M | 0.124% | US |
| Neuberger Berman Loan Advisers CLO 45 Ltd. Neuberger Berman Loan Advisers CLO 45 Ltd., S… | — | 64134MAJ5 US64134MAJ53 | ABS-CBDO CORP | 1,000,000 PA | $1.00M | 0.124% | KY |
| Roche Holding AG | — | — CH1499059983 | EC CORP | 2,490 NS | $993.7K CHF | 0.123% | CH |
| Accenture plc Accenture plc, Class A | ACN | — IE00B4BNMY34 | EC CORP | 4,954 NS | $982.3K | 0.121% | IE |
| FNMA FNMA, 30 Year | — | 3140XGML0 US3140XGML09 | ABS-MBS USGSE | 1,053,279.11 PA | $974.9K | 0.120% | US |
| CRH plc | CRH | — IE0001827041 | EC CORP | 9,192 NS | $966.3K | 0.119% | IE |
| Seagate Technology Holdings plc | STX | — IE00BKVD2N49 | EC CORP | 2,453 NS | $961.0K | 0.119% | IE |
Positions resolved to the master through ISIN, then rolled up through the taxonomy. 39.4% of reported value reaches a classification.
Percentages are of the reported value of positions above ($883.38M), not of the fund’s net assets ($809.44M). The two differ by cash, derivatives filed with no market value, and rounding.